drug class for glutathione solution Conjugate - an overview Glutathione-Mediated Conjugation of Anticancer Drugs:
Description
Letsinger (1970) J

Splitting the dose or adding a second daily injection is not part of the clinical protocol and may not improve outcomes

Reduction of cellular iron via chelators, including ciclopirox (CPX), di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and deferoxamine (DFO) [75], in addition to TFR1 silencing [64] have been shown to inhibit mTORC1 activity in cancer cells

However, it should be noted that [4Fe-4S] 2+ clusters can also be disassembled by ONOO (Kennedy et al., 1997)

This is the main reason why many early studies suggested that oral glutathione was not effective

doi: 10.1016/0006-2952(91)90363-A
